Aciphin (Inj) 2mg vial i.v

Aciphin 2g IV Injection — Ceftriaxone 2000mg High-Dose Intravenous

1. Indications

Aciphin® 2g IV is the high-dose formulation of ceftriaxone for severe, life-threatening bacterial infections requiring maximum once-daily IV dosing. Primary indications: bacterial meningitis (2–4g/day — highest priority indication for 2g dose); severe community-acquired pneumonia and hospital-acquired pneumonia; severe sepsis and septic shock; complicated intra-abdominal infections; severe urinary tract infections and complicated pyelonephritis; severe skin, soft tissue, bone and joint infections; endocarditis (in combination); severe typhoid and paratyphoid fever with complications; febrile neutropenia; infections in immunocompromised patients (oncology, HIV, post-transplant); and surgical prophylaxis for high-risk procedures requiring broad-spectrum coverage.

Diabetes relevance: The 2g dose is used in hospitalised diabetic patients with severe infections — necrotising fasciitis, severe diabetic foot infection with systemic signs, bacteraemia, hospital-acquired pneumonia, and meningitis. The 2g dose maintains therapeutic CSF concentrations for meningitis and achieves bone concentrations effective for osteomyelitis complicating diabetic foot.

2. Mechanism of Action

Ceftriaxone inhibits bacterial cell wall synthesis by irreversibly binding penicillin-binding proteins (PBPs), blocking the final cross-linking step of peptidoglycan biosynthesis. This leads to cell wall weakening, osmotic lysis, and bacterial cell death (bactericidal). The 2g dose achieves tissue concentrations far exceeding the MIC for susceptible organisms, providing enhanced bacterial killing in deep-seated, high-inoculum infections. Broad spectrum: S. pneumoniae, N. meningitidis, H. influenzae, Enterobacteriaceae, E. coli, K. pneumoniae, Salmonella typhi, Proteus spp., S. aureus (MSSA).

3. Dosage & Administration

Adults — severe infections: 2g IV once daily. Meningitis: 2–4g/day (as 2g every 12–24h). Septicaemia / severe sepsis: 2g IV once daily.
Children — severe/meningitis: 100 mg/kg/day IV (max 4g/day).
IV Reconstitution: Dissolve 2g in 20ml Water for Injection BP (2×10ml WFI ampoules provided). For slow IV bolus: give over minimum 5 minutes via butterfly needle. For IV infusion: further dilute in 100–250ml 0.9% NaCl or 5% dextrose and infuse over 30 minutes.
Renal impairment: Max 2g/day (no further reduction needed for hepatorenal dual elimination). In combined severe renal AND hepatic failure: monitor plasma levels. Not removed by dialysis.
Duration: 10–14 days for meningitis, 14–21 days for osteomyelitis, 4–7 days for surgical prophylaxis.

4. Side Effects

At 2g dose, same profile as lower doses but slightly higher frequency. GI: nausea, vomiting, diarrhoea. C. difficile-associated diarrhoea (CDAD) — report persistent diarrhoea. Haematological: eosinophilia, thrombocytosis/thrombocytopenia, leucopaenia — especially in prolonged therapy. Biliary: sludge/pseudolithiasis (reversible; commoner at higher doses). Hepatic: transient raised ALT/AST/bilirubin. CNS: at very high doses (4g) — seizures rarely reported. IV site: phlebitis. Hypersensitivity: rash, urticaria; rarely anaphylaxis. CRITICAL: Fatal calcium-IV precipitation — NEVER mix with Ringer's Lactate, Hartmann's, or any calcium-containing IV fluid, including in same line.

5. Contraindications

Hypersensitivity to ceftriaxone or cephalosporins; penicillin anaphylaxis history; hyperbilirubinaemic neonates; premature neonates; concurrent calcium-containing IV solutions (especially neonates — fatal). Combined severe renal AND hepatic failure (monitor levels).

6. Warnings & Precautions

Full anaphylaxis precautions required — epinephrine, antihistamine, resuscitation ready. Monitor FBC, LFTs, bilirubin in prolonged high-dose therapy. CDAD monitoring. Avoid all calcium-containing IV lines/fluids — use dedicated IV line with saline flush. For meningitis doses (4g/day), neurological monitoring for seizures. Do not use in neonates with hyperbilirubinaemia.

7. Drug Interactions

Aminoglycosides: synergistic — always separate IV lines, never mix in same syringe/bag. Warfarin: INR prolongation (monitor closely at 2g dose). Calcium-containing IV fluids: ABSOLUTELY CONTRAINDICATED. Loop diuretics, NSAIDs: monitor closely. Oral contraceptives: may reduce efficacy (advise additional contraception).

8. Pharmacokinetics

100% IV bioavailability. Protein binding 85–95% (concentration-dependent — slight reduction at 2g). Half-life 6–9h. Dual elimination: ~50% renal, ~50% biliary. At 2g dose, achieves bactericidal CSF concentrations (critical for meningitis), bone concentrations effective for osteomyelitis, and sustained serum levels exceeding MIC for 24h for susceptible organisms. Not dialyzable.

9. Storage

Store below 30°C, protected from light and moisture. After reconstitution with Water for Injection: stable 6h at room temperature (25°C), 24h at 2–8°C. Discard unused portion — do not store reconstituted solution.

10. Course Completion

Complete the full prescribed course as directed by physician. For meningitis: typically 10–14 days. For bone infections: 4–6 weeks (IV then oral step-down). Early discontinuation risks relapse, seeding, and resistance development.

11. Overdose

No specific antidote. Not removed by haemodialysis or peritoneal dialysis. Supportive management. At very high doses, monitor for seizures and electrolyte disturbance. Calcium precipitation risk if calcium-containing fluids are co-administered — treat as medical emergency.

12. Clinical Evidence

WHO Essential Medicine. First-line therapy for bacterial meningitis (WHO, NICE, IDSA guidelines). First-line for severe typhoid fever in Bangladesh (MDR strains). Included in surviving sepsis campaign protocols. In Bangladesh, Aciphin® 2g IV is the standard hospital formulary choice for meningitis, severe typhoid, and complicated diabetic foot infection with systemic bacteraemia.

13. Patient Counselling

For use in hospital under physician supervision only. Report any skin rash, breathing difficulty, severe diarrhoea, or signs of allergic reaction immediately. This is a hospital-grade high-dose antibiotic. The pack contains 2 ampoules of Water for Injection (IV use only). Do not use this pack for intramuscular injection — an IM-specific pack with lidocaine solvent is available separately for IM use.

Frequently Asked Questions (FAQ)

Q1. When is the 2g dose of ceftriaxone required instead of the standard 1g?
The 2g IV once-daily dose is indicated for severe, high-stakes infections: bacterial meningitis (2–4g/day to achieve bactericidal CSF levels), severe sepsis/septic shock, hospital-acquired pneumonia, complicated bacteraemia, and necrotising fasciitis. For most community-acquired infections (UTI, skin infections, uncomplicated pneumonia), the 1g dose is sufficient. Escalating to 2g provides higher tissue drug concentrations and extends time above MIC in anatomical compartments with limited penetration such as the CNS and bone.

Q2. Why does the Aciphin 2g pack come with two 10ml Water for Injection ampoules?
Ceftriaxone 2g requires 20ml of solvent for complete dissolution and proper concentration for IV administration. Using two separate 10ml WFI ampoules ensures the correct volume is available without risk of under-dissolution. The reconstituted 2g in 20ml solution may be further diluted in 100–250ml 0.9% NaCl or 5% dextrose for a 30-minute infusion — the preferred method at this dose to reduce injection site reactions and improve tolerability.

Q3. Is ceftriaxone 2g safe in patients with renal failure?
Yes — ceftriaxone's unique biliary dual elimination pathway means that approximately 50% of the dose is excreted via bile (unchanged) regardless of kidney function. The 2g daily dose is the standard maximum regardless of renal impairment severity, as the liver compensates for reduced renal clearance. The only situation requiring extra caution is simultaneous severe renal AND hepatic failure — in that case, drug levels should be monitored. No dose adjustment is needed in isolated renal failure including dialysis patients (not dialyzed).

Q4. Can ceftriaxone 2g IV be used for bacterial meningitis in Bangladesh?
Yes — ceftriaxone is the WHO-recommended first-line treatment for bacterial meningitis, including in Bangladesh. Typical adult dose: 2g IV every 12h (4g/day) for 10–14 days for N. meningitidis meningitis; 2g IV every 12h for 10–14 days for pneumococcal meningitis. Ceftriaxone achieves excellent CSF penetration (10–40% of serum levels when meninges are inflamed), making it bactericidal against the major causes of bacterial meningitis in Bangladesh. It is the antibiotic of choice when Gram-negative coverage is needed alongside Gram-positive cover.

⚕ Medical Disclaimer: Aciphin® 2g IV is a high-dose prescription antibiotic for hospital use by trained healthcare professionals only. Information sourced from ACI Pharmaceuticals Ltd. official prescribing data and WHO/IDSA guidelines. Educational purposes only.